Updated On: 05 February, 2026 10:13 AM IST | New Delhi | IANS
The new vaccine offers a potential breakthrough against a disease whose fatality rate is estimated to be between 40 per cent and 75 per cent

Image for representational purpose only. Photo Courtesy: File pic
A team of researchers in Japan has announced a clinical trial to confirm a vaccine's efficacy against the deadly Nipah virus in humans.
The vaccine candidate developed at the University of Tokyo is set to start clinical trials in Belgium in April, Nikkei Asia, a Japan-based English-language news magazine, reported.